$250 Million is the total value of Altium Capital Management LP's 127 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 45.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $10,756,000 | +20.6% | 615,000 | +12.8% | 4.30% | +44.2% |
| BLU | Sell | BELLUS HEALTH INC NEW | $8,427,000 | -15.5% | 912,000 | -37.1% | 3.37% | +1.0% |
| ADMA | Buy | ADMA BIOLOGICS INC | $7,920,000 | +31.1% | 4,000,000 | +21.2% | 3.17% | +56.8% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $7,396,000 | -36.2% | 1,162,869 | -53.4% | 2.96% | -23.7% |
| New | PEPPERLIME HEALTH ACQUSTN CO | $7,251,000 | – | 735,000 | +100.0% | 2.90% | – | |
| LNTH | Buy | LANTHEUS HLDGS INC | $5,811,000 | +162.7% | 88,000 | +120.0% | 2.32% | +214.2% |
| STAA | New | STAAR SURGICAL CO | $5,320,000 | – | 75,000 | +100.0% | 2.13% | – |
| INSM | INSMED INC | $5,285,000 | -16.1% | 268,000 | 0.0% | 2.12% | +0.3% | |
| GKOS | Buy | GLAUKOS CORP | $5,178,000 | -4.7% | 114,000 | +21.3% | 2.07% | +13.9% |
| CBAY | CYMABAY THERAPEUTICS INC | $5,163,000 | -5.1% | 1,750,000 | 0.0% | 2.07% | +13.4% | |
| MBTC | NOCTURNE ACQUISITION CORPordinary shares | $5,095,000 | +1.1% | 500,000 | 0.0% | 2.04% | +20.9% | |
| New | QUIDELORTHO CORP | $4,859,000 | – | 50,000 | +100.0% | 1.94% | – | |
| INSP | Buy | INSPIRE MED SYS INC | $4,384,000 | +6.7% | 24,000 | +50.0% | 1.75% | +27.7% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $4,281,000 | +210.9% | 75,000 | +233.3% | 1.71% | +271.6% |
| GH | New | GUARDANT HEALTH INC | $4,236,000 | – | 105,000 | +100.0% | 1.70% | – |
| GH | New | GUARDANT HEALTH INCcall | $4,034,000 | – | 100,000 | +100.0% | 1.61% | – |
| MYGN | Buy | MYRIAD GENETICS INC | $4,016,000 | +38.9% | 221,000 | +92.7% | 1.61% | +66.0% |
| CCXI | New | CHEMOCENTRYX INC | $3,965,000 | – | 160,000 | +100.0% | 1.59% | – |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $3,960,000 | +0.6% | 400,000 | 0.0% | 1.58% | +20.3% | |
| NVRO | Buy | NEVRO CORP | $3,901,000 | -30.0% | 89,000 | +15.6% | 1.56% | -16.3% |
| New | AMYLYX PHARMACEUTICALS INCput | $3,852,000 | – | 200,000 | +100.0% | 1.54% | – | |
| AKYA | New | AKOYA BIOSCIENCES INC | $3,804,000 | – | 296,000 | +100.0% | 1.52% | – |
| INGN | New | INOGEN INC | $3,772,000 | – | 156,000 | +100.0% | 1.51% | – |
| TRVI | New | TREVI THERAPEUTICS INC | $3,608,000 | – | 1,284,000 | +100.0% | 1.44% | – |
| VSTM | Buy | VERASTEM INC | $3,480,000 | -16.4% | 3,000,000 | +1.7% | 1.39% | 0.0% |
| DXCM | Buy | DEXCOM INC | $3,279,000 | -48.7% | 44,000 | +252.0% | 1.31% | -38.7% |
| XTNT | XTANT MED HLDGS INC | $3,245,000 | -23.6% | 6,246,291 | 0.0% | 1.30% | -8.7% | |
| CARA | Buy | CARA THERAPEUTICS INC | $3,225,000 | +60.8% | 353,200 | +114.1% | 1.29% | +92.3% |
| Buy | PROCEPT BIOROBOTICS CORP | $3,204,000 | +94.5% | 98,000 | +108.2% | 1.28% | +132.7% | |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $3,157,000 | -33.6% | 700,000 | +8.5% | 1.26% | -20.6% |
| LIVN | LIVANOVA PLC | $3,124,000 | -23.7% | 50,000 | 0.0% | 1.25% | -8.7% | |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INCcall | $2,888,000 | -75.6% | 365,100 | +7202.0% | 1.16% | -70.8% |
| OCUL | OCULAR THERAPEUTIX INC | $2,794,000 | -18.8% | 695,000 | 0.0% | 1.12% | -2.9% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $2,772,000 | -24.1% | 440,000 | 0.0% | 1.11% | -9.2% | |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $2,716,000 | +45.2% | 85,000 | +57.4% | 1.09% | +73.6% |
| KURA | New | KURA ONCOLOGY INC | $2,695,000 | – | 147,000 | +100.0% | 1.08% | – |
| MASS | New | 908 DEVICES INC | $2,574,000 | – | 125,000 | +100.0% | 1.03% | – |
| TMPM | TURMERIC ACQUISITION CORPcl a | $2,518,000 | +0.6% | 254,000 | 0.0% | 1.01% | +20.4% | |
| KRMD | REPRO MED SYS INC | $2,519,000 | -11.5% | 995,500 | 0.0% | 1.01% | +5.8% | |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $2,439,000 | – | 50,000 | +100.0% | 0.98% | – |
| KROS | Sell | KEROS THERAPEUTICS INC | $2,431,000 | -64.5% | 88,000 | -30.2% | 0.97% | -57.6% |
| SWAV | Sell | SHOCKWAVE MED INC | $2,294,000 | -51.9% | 12,000 | -47.8% | 0.92% | -42.5% |
| ISEE | IVERIC BIO INC | $2,270,000 | -42.8% | 236,000 | 0.0% | 0.91% | -31.7% | |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $2,225,000 | -0.1% | 225,000 | 0.0% | 0.89% | +19.3% | |
| ACET | Sell | ADICET BIO INC | $2,190,000 | -29.2% | 150,000 | -3.2% | 0.88% | -15.4% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $2,180,000 | -51.4% | 150,000 | -38.3% | 0.87% | -41.9% |
| GOSS | New | GOSSAMER BIO INC | $2,176,000 | – | 260,000 | +100.0% | 0.87% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $2,145,000 | – | 22,000 | +100.0% | 0.86% | – |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $2,056,000 | – | 116,000 | +100.0% | 0.82% | – |
| GIGINTERNATIONAL1 INC | $2,010,000 | +0.5% | 200,000 | 0.0% | 0.80% | +20.2% | ||
| TG VENTURE ACQUISITION CORPunit 08/15/2028 | $2,000,000 | -0.2% | 200,000 | 0.0% | 0.80% | +19.2% | ||
| CHAVANT CAPITAL ACQUISITN COordinary shares | $1,996,000 | +0.7% | 200,000 | 0.0% | 0.80% | +20.5% | ||
| LAKESHORE ACQUISITION I CORPordinary shares | $1,997,000 | +0.8% | 200,000 | 0.0% | 0.80% | +20.5% | ||
| JYAC | JIYA ACQUISITION CORP | $1,976,000 | +0.5% | 200,000 | 0.0% | 0.79% | +20.2% | |
| AXSM | New | AXSOME THERAPEUTICS INCput | $1,915,000 | – | 50,000 | +100.0% | 0.77% | – |
| Buy | HILLMAN SOLUTIONS CORP | $1,909,000 | -18.0% | 221,000 | +12.8% | 0.76% | -1.9% | |
| ILMN | Sell | ILLUMINA INC | $1,844,000 | -52.0% | 10,000 | -9.1% | 0.74% | -42.6% |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1,767,000 | -35.2% | 224,541 | 0.0% | 0.71% | -22.6% | |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $1,645,000 | -38.2% | 13,000 | -38.1% | 0.66% | -26.2% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $1,618,000 | -16.0% | 73,000 | +10.3% | 0.65% | +0.3% |
| GOEDWS | 1847 GOEDEKER INC*w exp 06/02/202 | $1,588,000 | -58.0% | 6,103,824 | 0.0% | 0.64% | -49.8% | |
| OM | Buy | OUTSET MED INC | $1,544,000 | -34.6% | 103,880 | +99.7% | 0.62% | -21.8% |
| DIGITAL HEALTH ACQUISITION Cunit 11/02/2026 | $1,515,000 | 0.0% | 150,000 | 0.0% | 0.61% | +19.5% | ||
| AULT DISRUPTIVE TECHS CORP | $1,503,000 | +0.5% | 150,000 | 0.0% | 0.60% | +20.0% | ||
| RZLT | New | REZOLUTE INC | $1,328,000 | – | 411,000 | +100.0% | 0.53% | – |
| MORF | MORPHIC HLDG INC | $1,302,000 | -46.0% | 60,000 | 0.0% | 0.52% | -35.4% | |
| TWND | TAILWIND ACQUISITION CORP | $1,278,000 | +0.6% | 128,414 | 0.0% | 0.51% | +20.2% | |
| IMGN | Sell | IMMUNOGEN INC | $1,260,000 | -71.2% | 280,000 | -69.6% | 0.50% | -65.6% |
| ALT | Sell | ALTIMMUNE INC | $1,154,000 | -41.2% | 98,659 | -69.4% | 0.46% | -29.6% |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $1,101,000 | – | 39,000 | +100.0% | 0.44% | – |
| Sell | 2SEVENTY BIO INC | $1,096,000 | -44.1% | 83,000 | -27.8% | 0.44% | -33.2% | |
| RELATIVITY ACQUISITION CORPunit 02/10/2027 | $1,025,000 | +1.8% | 100,000 | 0.0% | 0.41% | +21.7% | ||
| MURPHY CANYON ACQUISITION COunit 01/25/2027 | $1,012,000 | +0.2% | 100,000 | 0.0% | 0.40% | +19.8% | ||
| INDUSTRIAL HUMAN CAPITAL INC | $1,003,000 | +0.1% | 100,000 | 0.0% | 0.40% | +19.7% | ||
| WESTERN ACQSTN VENTURES CORPunit 09/01/2026 | $1,000,000 | 0.0% | 100,000 | 0.0% | 0.40% | +19.4% | ||
| BLSA | BCLS ACQUISITION CORP | $990,000 | +0.3% | 100,000 | 0.0% | 0.40% | +20.0% | |
| OMEG | OMEGA ALPHA SPACcl a | $985,000 | +0.3% | 100,000 | 0.0% | 0.39% | +19.8% | |
| OPY ACQUISITION CORP I | $984,000 | +0.4% | 100,000 | 0.0% | 0.39% | +20.1% | ||
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $981,000 | +0.1% | 100,000 | 0.0% | 0.39% | +19.8% | |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $965,000 | -5.6% | 227,000 | 0.0% | 0.39% | +12.9% | |
| New | HOLLEY INC | $840,000 | – | 80,000 | +100.0% | 0.34% | – | |
| COLISEUM ACQUISITION CORP | $827,000 | +0.2% | 85,000 | 0.0% | 0.33% | +19.9% | ||
| New | PEPGEN INC | $794,000 | – | 80,000 | +100.0% | 0.32% | – | |
| RENOVACOR INC | $788,000 | -52.2% | 388,845 | 0.0% | 0.32% | -42.9% | ||
| ANGO | New | ANGIODYNAMICS INC | $767,000 | – | 39,640 | +100.0% | 0.31% | – |
| GRIL | MUSCLE MAKER INC | $692,000 | -27.0% | 1,796,961 | 0.0% | 0.28% | -12.6% | |
| New | LIANBIOsponsored ads | $681,000 | – | 315,191 | +100.0% | 0.27% | – | |
| STOK | New | STOKE THERAPEUTICS INC | $634,000 | – | 48,000 | +100.0% | 0.25% | – |
| ATHA | New | ATHIRA PHARMA INCcall | $610,000 | – | 200,100 | +100.0% | 0.24% | – |
| DOUBLEDOWN INTERACTIVE CO LTads | $588,000 | -18.6% | 60,876 | 0.0% | 0.24% | -2.9% | ||
| GERN | New | GERON CORP | $576,000 | – | 371,367 | +100.0% | 0.23% | – |
| ALKS | New | ALKERMES PLC | $536,000 | – | 18,000 | +100.0% | 0.21% | – |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $532,000 | -90.4% | 28,000 | -86.4% | 0.21% | -88.6% |
| GSR II METEORA ACQUISITN CORunit 02/24/2027 | $499,000 | -1.4% | 50,000 | 0.0% | 0.20% | +18.3% | ||
| CLBR | COLOMBIER ACQUISITION CORPcl a | $488,000 | +0.8% | 50,000 | 0.0% | 0.20% | +20.4% | |
| SAGE | New | SAGE THERAPEUTICS INC | $485,000 | – | 15,000 | +100.0% | 0.19% | – |
| SURGEPAYS INC*w exp 10/22/202 | $300,000 | +34.5% | 250,000 | 0.0% | 0.12% | +60.0% | ||
| ZEVWS | LIGHTNING EMOTORS INC*w exp 05/18/202 | $255,000 | -4.9% | 652,173 | 0.0% | 0.10% | +13.3% | |
| HARBOR CUSTOM DEVELOPMENT IN*w exp 10/04/202 | $244,000 | +1.7% | 650,000 | 0.0% | 0.10% | +22.5% | ||
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $223,000 | -51.6% | 941,176 | 0.0% | 0.09% | -42.2% | ||
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $199,000 | +16.4% | 97,467 | 0.0% | 0.08% | +40.4% | |
| DBGI | New | DIGITAL BRANDS GROUP INC | $195,000 | – | 1,000,000 | +100.0% | 0.08% | – |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $158,000 | – | 17,400 | +100.0% | 0.06% | – |
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $116,000 | -32.2% | 600,000 | 0.0% | 0.05% | -19.3% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $100,000 | +1.0% | 10,000 | 0.0% | 0.04% | +21.2% | |
| CINGULATE INC*w exp 12/10/202 | $85,000 | -21.3% | 270,000 | 0.0% | 0.03% | -5.6% | ||
| PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $76,000 | -50.0% | 367,500 | 0.0% | 0.03% | -41.2% | ||
| DIRECT DIGITAL HOLDINGS INC*w exp 02/15/202 | $70,000 | -46.6% | 180,000 | 0.0% | 0.03% | -36.4% | ||
| New | SONENDO INC | $65,000 | – | 37,572 | +100.0% | 0.03% | – | |
| NEXGEL INC*w exp 12/01/202 | $63,000 | -28.4% | 225,000 | 0.0% | 0.02% | -13.8% | ||
| CEA INDUSTRIES INC*w exp 02/11/202 | $60,000 | -64.9% | 250,000 | 0.0% | 0.02% | -57.9% | ||
| RENOVACOR INC*w exp 99/99/999 | $51,000 | -79.5% | 731,561 | 0.0% | 0.02% | -75.9% | ||
| LAKESHORE ACQUISITION I CORP*w exp 07/15/202 | $27,000 | -49.1% | 150,000 | 0.0% | 0.01% | -38.9% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 09/25/202 | $24,000 | -68.4% | 200,000 | 0.0% | 0.01% | -60.0% | |
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $20,000 | -81.0% | 500,000 | 0.0% | 0.01% | -77.1% | |
| SURROZEN INC*w exp 08/01/203 | $16,000 | -23.8% | 82,233 | 0.0% | 0.01% | -14.3% | ||
| OPY ACQUISITION CORP I*w exp 09/22/202 | $9,000 | -55.0% | 50,000 | 0.0% | 0.00% | -42.9% | ||
| CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $11,000 | -63.3% | 150,000 | 0.0% | 0.00% | -60.0% | ||
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $9,000 | -64.0% | 133,333 | 0.0% | 0.00% | -50.0% | |
| AULT DISRUPTIVE TECHS CORP*w exp 99/99/999 | $7,000 | -63.2% | 112,500 | 0.0% | 0.00% | -50.0% | ||
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $8,000 | -66.7% | 84,666 | 0.0% | 0.00% | -62.5% | |
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $6,000 | -77.8% | 75,000 | 0.0% | 0.00% | -77.8% | |
| GIGINTERNATIONAL1 INC*w exp 04/19/202 | $4,000 | -77.8% | 50,000 | 0.0% | 0.00% | -66.7% | ||
| INDUSTRIAL HUMAN CAPITAL INC*w exp 11/27/202 | $4,000 | -77.8% | 100,000 | 0.0% | 0.00% | -66.7% | ||
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $3,000 | -70.0% | 28,333 | 0.0% | 0.00% | -66.7% | ||
| CLBRWS | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $2,000 | -60.0% | 16,666 | 0.0% | 0.00% | -50.0% | |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -202,276 | -100.0% | -0.03% | – |
| VRCA | Exit | VERRICA PHARMACEUTICALS INC | $0 | – | -97,887 | -100.0% | -0.27% | – |
| VQSLF | Exit | VIQ SOLUTIONS INC | $0 | – | -489,417 | -100.0% | -0.27% | – |
| Exit | ACHIEVE LIFE SCIENCES INC | $0 | – | -122,000 | -100.0% | -0.31% | – | |
| CUTR | Exit | CUTERA INC | $0 | – | -15,000 | -100.0% | -0.35% | – |
| PROF | Exit | PROFOUND MED CORP | $0 | – | -124,945 | -100.0% | -0.38% | – |
| CRIS | Exit | CURIS INC | $0 | – | -540,800 | -100.0% | -0.43% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -299,800 | -100.0% | -0.47% | – |
| Exit | SOMALOGIC INC | $0 | – | -180,000 | -100.0% | -0.48% | – | |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -663,800 | -100.0% | -0.59% | – |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -253,000 | -100.0% | -0.61% | – | |
| SLN | Exit | SILENCE THERAPEUTICS PLCads | $0 | – | -109,000 | -100.0% | -0.69% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -66,000 | -100.0% | -0.75% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -300,000 | -100.0% | -1.14% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -204,000 | -100.0% | -1.50% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -93,000 | -100.0% | -1.52% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -105,000 | -100.0% | -1.71% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -120,000 | -100.0% | -1.76% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -50,000 | -100.0% | -1.95% | – |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -79,000 | -100.0% | -1.95% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -56,000 | -100.0% | -2.11% | – |
| Exit | PEPPERLIME HEALTH ACQUSTN COunit 99/99/9999 | $0 | – | -735,000 | -100.0% | -2.42% | – | |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -386,000 | -100.0% | -3.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.